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patient’s arm to expose the axillary artery, which I used
as the cannulation site. The aortic valve replacement
was successfully performed with circulatory arrest.
Bruce Lytle has expanded this idea and refined the
process of cannulating the subclavian artery for this
problem. The idea has been taken further with cannula-
tion of the innominate artery for arterial return in these
difficult situations.
William Shakespeare’s quote “What’s past is prologue”
is engraved on the United States Archives in Washington,
DC. In the early 1980s, my co-workers and I described
use of a balloon cannula to occlude the ascending aorta
for patients with a calcified ascending aorta. This led to an
attempt to develop an arterial return cannula with an
occlusion balloon and a port for cardioplegia and venting.
Although this effort was unsuccessful because balloon
technology had not been adequately developed, it did pro-
vide impetus for development of the Heartport technolo-
gy and is the first paper cited in the patent application for
the Heartport aortic occlusion cannula. Understanding
previous efforts in dealing with the problem can lead to
important new developments.
Robert Frost observed that all thought is a feat of
association: “Having what is in front of you brings up
something in your mind that you almost didn’t know
you knew. Putting this-and-that together. Then, click.”
In the early days of mitral valve surgery, we fully
embraced the approaches and the retractor developed
by Alain Carpentier. We were, however, unable to
achieve precise positioning of the retractor arm in all
cases. At that time, we had a huge experience dissecting
internal thoracic arteries with a Favaloro retractor. This
retractor had universal joints that allowed positioning of
the retractor blades for any angle or location. We com-
bined these universal joints with the retractor Denton
Cooley had developed for exposure of the mitral valve.
The combination proved to be a self-retaining retractor
that was infinitely variable and has been in continuous
use since the mid 1980s.
Another example of the importance of association in
developing new technology is attempts to develop a flex-
ible handle clamp. We were trying to develop a clamp
David Lawrence summarized the development of newtechnology when he said, “The world fears a new
experience more than it fears anything....” This is cer-
tainly true of thoracic surgeons. There are few arenas in
which straying from the tried-and-true has more impact
than in an operating room. It is my privilege to present
the development of new technology in thoracic surgery
and to share it through some wisdom of the ages.
Mark Twain said, “the name of the greatest of all
inventors is accident.” A classic example of this truth is
one of the best accidents that ever happened in cardio-
thoracic surgery. In 1957, Mason Sones, a pediatric car-
diologist, mistakenly injected the right coronary artery
with dye during an angiographic examination of a
young man with aortic stenosis. Sones immediately rec-
ognized the problem and pulled the catheter out of the
artery while the injection of dye continued. The heart
stopped but started again spontaneously.
Sones happened by one afternoon while I was review-
ing this historic angiogram and said, “That day I realized
that I had discovered something very important.” Clearly,
discovery favored the prepared mind. Soon thereafter,
Sones deliberately repeated this exercise and continued
to refine the technique and to define coronary anatomy
and the pathoanatomy of coronary atherosclerosis, the
most important cause of death in the western world.
In 1672, Wycherly stated in one of his plays, “neces-
sity is the mother of invention.” It is a line that has been
frequently quoted because it is so true. Several years
ago, in preparation to perform aortic valve replacement,
I found the ascending aorta entirely calcified and both
femoral arteries occluded. Recognizing the danger of
cannulating either one of these vessels, I raised the
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The specialty of cardiothoracic surgery should be one of constant innova-
tion. Albert Einstein was a man of vision who said, “Imagination is more
important than knowledge.” With most technology expected to be obsolete
in 5-7 years, thoracic surgeons need to draw from their imaginations to find
innovative surgical solutions for the future. (J Thorac Cardiovasc Surg
2001;121:S29-31)
with a flexible handle so that we could activate the occlu-
sion mechanism from a distance and keep the handle
from protruding into the surgeon’s line of sight. The
principle of the activation of bicycle hand brakes con-
nected to the brake portion by cable came to mind. From
this hypothesis and over a year and a half of trial and
error, we developed a clamp that allowed us to clamp the
aorta and position the clamp out of the way. With this
innovation, the aorta could be clamped with little com-
promise of the working space of a very small incision.
The same thought process extended to our use of
venous drainage through small incisions. In the late
1970s and early 1980s, we developed a system for plac-
ing vacuum on a cardiotomy reservoir and then auto-
transfusing the shed mediastinal blood. A venous reser-
voir was developed that had an extra port so that we could
use this in a similar way. After struggling for adequate
visualization around large venous cannulas through a
small incision, it occurred to me that perhaps we could
use a smaller venous cannula in the heart by applying
negative pressure to the venous reservoir on the vacuum
port that was in place for another purpose. We connected
wall suction to the cardiotomy and were able to use
smaller venous cannulas and reap other unexpected
advantages. We no longer had to prime the venous lines
so that we could siphon the blood and we no longer had
to have the oxygenator as close to the floor as possible to
increase the siphon affect. This allowed us to move the
heart-lung machine closer to the field and substantially
reduce the prime of the cardiopulmonary bypass to less
than 1 L of crystalloid solution. This resulted in higher
hematocrits on pump and less postoperative bleeding. In
a randomized study, the percentage of patients undergo-
ing transfusion decreased from 40% with conventional
cardiopulmonary bypass to 15% for vacuum-assist
venous drainage. In addition, air leaks around venous
cannulas no longer caused air lock in the venous lines,
which would interrupt the venous drainage.
Isaac Newton allegedly was asked how he discovered
the laws of gravity. Newton is reputed to have responded
that it was by thinking about it all the time. Early in my
experience with mitral valve repair, I was consumed with
a particular problem and thought about it constantly. As
knowledge accumulated, I learned more about the physi-
ologic mechanism of the mitral valve. Echocardio-
graphers at Massachusetts General Hospital described the
saddle-shaped contour of the mitral annulus. Alain
Carpentier found that dilation of the mitral annulus
occurred along the posterior annulus and not uniformly
throughout the annulus. Several groups of investigators
recognized the potential for the development of systolic
anterior motion among patients undergoing mitral valve
repair. This information coalesced as we began to think
about the optimal annuloplasty ring that would produce
measured plication of the posterior annulus and would be
universally flexible. A search for a mechanism to accom-
plish this triggered thoughts about an embroidery hoop.
This wooden circle holds a piece of cloth taut during
embroidery. The stitches are pulled tight, but when the
ring is removed, there is a flexible piece of cloth. Using
this as a basis, we placed the embroidery hoop on the
concave portion of the annuloplasty cloth and were able
to achieve measured plication of the posterior annulus
that was universally flexible during the cardiac cycle.
Another valuable lesson was learned from this exer-
cise. This device languished for 5 years before it was
developed into a product because the manufacturer
could not be convinced of the usefulness of this
approach. This demonstrates F. M. Cornford’s observa-
tion that “nothing is ever done until everyone is con-
vinced that it ought to be done.”
Newton stated, “Pygmies placed on the shoulders of
giants see more than the giants themselves.” We are
fortunate that we, the members of our profession, stand
on the shoulders of many giants who have preceded us.
As I began to become interested in repair of aortic
valves, I became interested in repairing incompetent
bicuspid valves. I began to notice that bicuspid valves
were incompetent because of prolapse of conjoined
leaflets that were longer along the free edge than was
the opposite member. Earlier I had seen Alain
Carpentier resect a portion of one leaflet of a tricuspid
aortic valve and resuture it to correct prolapse of these
leaflets. I was also aware of the work of Duran and
Ankeney with plication of the annulus of the aortic
valve to increase leaflet coaptation. My coworkers and
I combined the procedures developed by both these
giants in thoracic surgery and were able to successful-
ly repair more than 150 incompetent bicuspid valves.
Victor Hugo said, “nothing is so powerful as an idea
whose time has come.” In the late 1970s and early
1980s, we were struggling with the problem of rup-
tured intraventricular septum. The thought occurred to
us that we could temporarily occlude the ventricular
septal defect with a balloon catheter that would go
through the defect and be inflated. From this idea—the
device was never successfully implanted—we expand-
ed and built on the experience of Noel Mills with col-
lapsing umbrellas. We developed a catheter for delivery
of two umbrellas that could be locked together and a
centering device that would keep them in the center of
the defect. We had hoped to use these catheters to close
atrial septal defects and patent ductus arteriosus. This
effort took place considerably before the development
of percutaneous transluminal coronary angioplasty and
the regular use of catheters for intervention. The com-
pany with which I was pursuing this idea decided that
delivery of material into a patient’s heart on the end of
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the catheter was not practical. The effort collapsed.
This was an idea whose time had not yet come.
Thomas Edison said, “Genius is one percent inspira-
tion, ninety-nine percent perspiration. Yes sir, it’s
mostly hard work.” He should have added that it may
not be successful. In 1970, John Kirklin, at the
University of Alabama, attempted to develop a closed-
loop system for controlling hypertension among
patients who had undergone surgical procedures.
Although he succeeded in doing this, the idea never
became commercially viable. In the early 1980s, my
coworkers and I picked up on his idea. An associate,
John Petre, developed a system to monitor arterial
blood pressure and put the information through a
microprocessor that would signal an infusion pump to
deliver sodium nitroprusside at the rate needed to
achieve a desired blood pressure. The work consumed
more than 5 years. It started with a Radio Shack com-
puter and became progressively more sophisticated. It
resulted in clinical trials at our institution, licensing
and commercial development by IVAC, and random-
ized trials in three institutions. These trials showed
much better control of blood pressure with the closed-
loop system than could be achieved by nurses regulat-
ing the nitroprusside infusion rate. This system was
approved by the US Food and Drug Administration and
was launched commercially. Another important lesson
was learned from this enterprise. The company that
developed the technology had little experience dealing
with intensive care specialists or cardiac surgeons. It
consequently had difficulty selling the product. After
dealing with five chief executive officers in the same
number of years, the company decided to stop manu-
facture of this product, although the device was highly
effective in controlling postoperative hypertension.
Whenever we embark on a project, we must remem-
ber the words of Toa Tzu (604 BC) who said, “A journey
of a thousand miles begins with a single step.” We were
concerned about the increasing incidence of stroke
among patients undergoing cardiac operations. At mor-
bidity and mortality conferences, our cardiac patholo-
gist, Norman Ratliff began to show slides of cholesterol
crystals in various organs. At the same time, trans-
esophageal echocardiography began to show athero-
sclerosis of the ascending and descending aortas. Gary
Roach and his coworkers, in a study reported in the New
England Journal of Medicine,1 found that age was
directly related to neurologic injury whether the injury
was frank stroke or neurologic dysfunction. To try to
understand the course of the neurologic injury, we
undertook a study of autopsy records to find the inci-
dence of atheroemboli in various organ systems. We
found that the incidence increased rapidly beginning at
60 years of age and had reached 30% by the time the
patients were 70 years of age. The incidence of athero-
sclerosis of the ascending aorta closely paralleled the
incidence of atheroemboli as age increased. There was
little or no incidence of atheroemboli without athero-
sclerosis of the ascending aorta. Recognizing that
manipulation of the ascending aorta was probably the
provocateur for atheroemboli, we eliminated the partial-
ly occluding clamp during proximal anastomosis. We
also were concerned that the jet lesion of blood coming
from the arterial return cannula in the ascending aorta
could dislodge atherosclerotic plaques in the ascending
aorta and arch by means of a sandblasting affect. Aware
that the underwater portion of freighters and submarines
had bulbous bows to deflect the bow wave, we used that
association to close the tip of the cannula and place a
deflecting tip to diffuse the jets through multiple side
ports. This decreased the velocity of the jet, making it
less traumatic on the aorta, decreased the resistance of
the arterial cannula by increasing the total orifice area,
and was associated with a lower incidence of stroke.
Although our attempts to avoid stroke during cardiac
operations have improved and our understanding of the
cause of stroke has increased, the problem has yet to be
eliminated. Achieving this will take substantial work
and will only be solved by substantially more work.
Louis Pasteur wrote, “Let me tell you the secret that has
led me to my goal. My strength lies solely through my
tenacity.” It will be through sheer tenacity that this dev-
astating problem in cardiac surgery will eventually be
eliminated.
Finally, let me share with all you would-be inventors
and innovators, a quote from Machiavelli’s The Prince:
“There’s nothing more difficult to plan, nor more dubi-
ous of success, nor more dangerous to manage than
creation of a new order of things. Whenever his ene-
mies have the ability to attack the innovator, they will
do so with a passion of partisans while others defend
him sluggishly so that the innovator and his party are
likely to be vulnerable.”
I can attest that new enterprise receives little support
and much criticism. Nonetheless, it is a wonderful pur-
suit. It is intellectually stimulating and, more impor-
tantly, is the only way to improve the quality of our
patients’ care. I encourage you to pursue it.
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